


Innocrin Pharmaceuticals
Pharmaceutical Manufacturing • Triangle, North Carolina, United States • 1-10 Employees
Company overview
| Headquarters | 4505 Emperor Blvd, Durham, NC 27703, US |
| Phone number | +19192379536 |
| Websites | |
| NAICS | 3254 |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
Key Contact at Innocrin Pharmaceuticals
Lisa Franklin
Director Clinical Operations
About Innocrin Pharmaceuticals
We are a privately held, clinical stage pharmaceutical company that develops novel, “best-in-class” oral CYP17 lyase inhibitors for the treatment of castration-resistant prostate cancer (CRPC) and potentially in other hormonally-driven conditions such as breast cancer, endometriosis, or congenital adrenal hyperlplasia.
Innocrin Pharmaceuticals revenue & valuation
| Annual revenue | $5,000,000 |
| Revenue per employee | $1,667,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $16,000,000 |
| Total funding | $28,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Explore Innocrin Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Innocrin Pharmaceuticals Tech Stack
Discover the technologies and tools that power Innocrin Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Caching
JavaScript libraries
JavaScript libraries
Maps
UI frameworks
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Frequently asked questions
4.8
40,000 users



